NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA
AI Summary
The National Institute for Pharmaceutical Technology and Education is a 501(c)(3) organization that focuses on advancing pharmaceutical technology through strategic grantmaking. In the filing year 2024, the organization awarded a total of $2.9 million across 13 grantees, operating on a relationship-based, invitation-only model. It does not accept unsolicited proposals; however, nonprofits can explore warm-introduction pathways through Impala's Funder Prospecting to engage with this funder.
Was this helpful?
This summary is AI-generated from ChatGPT. It’s meant to be helpful, but isn’t always perfect.
Mission Statement
The National Institute for Pharmaceutical Technology and Education (NIPTE) is a premier consortium of top universities working to advance pharmaceutical science, technology, and manufacturing. We collaborate with industry and regulatory agencies to drive innovation, enhance drug development efficiency, and strengthen the pharmaceutical workforce. Our research and education initiatives support modernized manufacturing, regulatory science, and supply chair resilience-ensuring safer, more effective, and more accessible medicines for patients. Through NIPTE, industry leaders and policymakers gain access to cutting-edge science and highly skilled talent pipeline, fostering a more robust and competitive pharmaceutical sector.
Cause Areas
2
Technology
Philanthropy
Explore this org's ecosystem
See top causes for this funder's grantees, who else funds them, and their grants.
Learn about Ecosystems


Explore this org's ecosystem
See top causes for this funder's grantees, who else funds them, and their grants.
Learn about Ecosystems
Grantee
Total Funding
Funding Share
RUTGERS THE STATE UNIVERSITY OF NJ
$1.3M
15%

PURDUE UNIVERSITY
$970.5K
11%
REGENTS OF THE UNIVERSITY OF MINNESOTA
$806.9K
10%
Evaluate your own portfolio
Understand the health of your own grantees and uncover signs of risk.


Evaluate your own portfolio
Understand the health of your own grantees and uncover signs of risk.
Total No. of Grants
10
Median 1st year grant
$119.3K
Median 2nd year grant
$143.7K
Top 3 Grants
Matched grants only
Grantee
Grant Size
Frequently Asked Questions
Can I submit an unsolicited grant proposal to NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA?
No. NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA does not accept unsolicited proposals. Funding is by invitation only.
Where does NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA give?
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA primarily gives to organizations located in New Jersey, Minnesota, and Virginia. These states represent the largest share of the foundation’s grantmaking by dollars awarded. Additional geographic details are available to registered users.
What size are NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA’s grants?
The largest share of grants from NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA fall in the $250 thousand to $500 thousand range. The median first-year grant is about $119 thousand. More detailed grant size data is available to registered users.
How many grants does NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA make each year?
In 2024, NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA awarded about 10 grants, totaling nearly $2.9 million. More detailed grant metrics are available to registered users.
Who did NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA fund recently?
In 2024, NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA awarded grants to about 10 grantees. Recent grantees include RUTGERS THE STATE UNIVERSITY OF NJ, PURDUE UNIVERSITY, and REGENTS OF THE UNIVERSITY OF MINNESOTA. More detailed information on all recent recipients is available to registered users.
How do we apply to NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA?
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY AND EDUCA does not accept unsolicited proposals. Funding is by invitation only.
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)